Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma. - Wikidata - awgldk - TriplyDB

Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma.

Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma.

http://www.wikidata.org/entity/Q38019862

about

Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers.Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis.Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma.High prevalence of antinuclear antibodies in children with thyroid autoimmunity.Stem cell therapy in autoimmune rheumatic diseases: a comprehensive review.Endothelial Dysfunction and Nailfold Videocapillaroscopy Pattern as Predictors of Digital Ulcers in Systemic Sclerosis: a Cohort Study and Review of the Literature.How should a district general hospital immunology service screen for anti-nuclear antibodies? An 'in-the-field' audit.The challenge of treating orphan disease.Relevance of clinical and autoantibody profiles in systemic sclerosis among Thais.Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis.Open questions in autoimmunity: discussions from the 2013 Controversies in Rheumatology and Autoimmunity Meeting.Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.

P2860

Q33766384-6FFBC136-03A4-4C06-B2F0-307DEF44E2FD Q36709262-C17E5A7A-E0E5-4688-818E-D4D8443A1D6A Q37690735-603A5F73-7347-4ECA-AF09-3056D5FAC722 Q37704573-A6A59FAC-CBB0-4BC6-806B-F1F43FC146A9 Q38242079-A5C5D07D-691D-4D49-BD96-AC6AC2B21A97 Q38542662-2C3DFAC3-3263-48AE-86D5-BD3CC701BD6A Q38938849-58CECB23-717C-4BA0-BC16-FE4EBD0D7216 Q39098238-354B2556-91AE-4C1D-8AFC-74287538A9F9 Q40291320-48D81E2E-B39E-4E35-A812-400C9F29C4A8 Q40748954-42CC894C-2993-4F27-83CB-1412EF8A2264 Q42356893-19B419A7-8AD1-42CB-822B-5B60D592D5ED Q49906728-FD39544E-34F7-4D56-A033-3FC4C1792596

P2860

Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma.

http://www.wikidata.org/entity/Q38019862

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma.

@en

type

label

Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma.

@en

prefLabel

Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma.

@en

P1433

Q38019862-495654C1-D5DB-4BE7-B2E5-1A8FADD03A9A

P1476

Q38019862-0EB00A94-A7E7-4CEF-AB85-93CD8CEA31D3

P2093

Q38019862-1C4A7DD1-5772-42BB-B13A-04C37DFCCEF7

Q38019862-914B75A8-07D4-4F32-8EC0-85AE0BD9C56E

Q38019862-A347EEE9-573F-47F1-BAA9-8F38BC2A820D

Q38019862-E5DE390C-A0E6-4D55-815F-0E19D5244F2F

P2860

Q38019862-050E8182-52B0-4FA5-9D2E-30B474225401

Q38019862-05887B67-C88E-48D9-95E0-AA9420DA2439

Q38019862-08B609BE-232F-4273-8217-B577268C8585

Q38019862-187B84FB-7749-4A36-8F5A-F26ED3CAF61C

Q38019862-1D0DFD37-9865-4791-B2E0-92FF60A39714

Q38019862-1D9E30A2-F644-4C7E-A2F4-A0F245661538

Q38019862-22E46A26-B0E4-437B-9073-A73670B80169

Q38019862-237772A6-422A-402D-B159-5510666BEFC2

Q38019862-2A7BB614-FE16-478D-B162-49FA91F14459

Q38019862-2E574ABD-1803-42FF-99F3-C1CE48CCD141

P2888

Q38019862-A07832D6-1353-4E01-BBC1-A9B6C65C97BE

P304

Q38019862-5FE24D11-F8C2-4729-B7F7-15EFC6EE7752

P31

Q38019862-8C3643A4-0C9C-4ECB-964E-C1CBF766F36C

P356

Q38019862-A8452BC6-869D-40A4-AD68-D494B49E0E68

P433

Q38019862-A1DBE9DE-DFB0-4B1B-A7EE-8CEF54B25BEF

P478

Q38019862-F1497344-D532-40BA-9AE1-6BFC9E7A7B1D

P50

Q38019862-BC930C69-4993-42D1-B630-4444BF4C3C6C

P577

Q38019862-34F8BCAE-DA85-4272-AB22-EB0B6A7563B8

P6179

Q38019862-EE35A690-9612-4A96-8A62-A858713C04DF

P698

Q38019862-727BA1B6-6214-44D6-924D-FE099B81CC72

P921

Q38019862-E8AE4ACB-D8DC-48AA-87DE-FD7BED6A0E69

P356

S12016-012-8331-1

P1433

Clinical Reviews in Allergy & Immunology

P1476

Impact of hallmark autoantibody reactivity on early diagnosis in scleroderma

@en

P2093

Christopher P Denton

http://www.w3.org/2001/XMLSchema#string

Pia Moinzadeh

http://www.w3.org/2001/XMLSchema#string

Svetlana I Nihtyanova

http://www.w3.org/2001/XMLSchema#string

Voon H Ong

http://www.w3.org/2001/XMLSchema#string

P2860

Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights

Clinical practice. Raynaud's Phenomenon.

Scleroderma renal crisis: patient characteristics and long-term outcomes.

Differentiation between primary and secondary Raynaud's phenomenon: a prospective study comparing nailfold capillaroscopy using an ophthalmoscope or stereomicroscope

Raynaud's phenomenon and the role of capillaroscopy.

Scleroderma--clinical and pathological advances.

Items for developing revised classification criteria in systemic sclerosis: Results of a consensus exercise

Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features

Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database

Changes in causes of death in systemic sclerosis, 1972-2002

P2888

s12016-012-8331-1

P304

249-255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12016-012-8331-1

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1042023375

http://www.w3.org/2001/XMLSchema#string

P698

22711501

http://www.w3.org/2001/XMLSchema#string

P921